Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

MedTech to Take Advantage of Digital Health Platform as a Service Model to Accelerate Digital Transformation across the Healthcare Industry
  • USA - English


News provided by

Frost & Sullivan

24 Feb, 2021, 17:32 IST

Share this article

Share toX

Share this article

Share toX

A proven, compliant platform can expedite market entry and optimize time and effort without building competencies internally, finds Frost & Sullivan

SANTA CLARA, Calif., Feb. 24, 2021 /PRNewswire/ -- MedTech and Life Sciences companies are transitioning beyond biopharmaceuticals, medical devices, and equipment to provide end-to-end solutions across the patient care continuum. The theme that runs through all these efforts is healthcare data; however, healthcare data management and analysis capabilities are difficult to procure. A domain-specific Platform as a Service (PaaS) that offers an easy to connect, secure, and compliant cloud and edge environment for secure data access and sharing among multiple stakeholders can be the secret sauce to a seamless digital transformation and rapid return on investment.

Frost & Sullivan's white paper, MedTech Industry Leverages Platform as a Service (PaaS) to Overcome Hurdles, Capitalize on Big Data and Truly Embrace Digital Transformation, discusses the various platform approaches that are available to support MedTech vendors in their digital transformation efforts. It analyzes the advantages of a platform approach for managing healthcare data from multiple sources; leveraging applications that enable MedTech companies to offer value to healthcare providers, professionals, and patients beyond their products and services; and contributing to improved outcomes.

To download the complimentary white paper, please visit: http://frost.ly/4pa

"teamplay has realistically opened up the options for R&D and digital transformation teams, within MedTech and Pharma companies, as they embark on programs relying on access to data and the ability to assimilate the same. This Digital Health Platform and its offerings help reduce the conundrum, that has plagued decision-makers, of investing in their own infrastructure that needs to remain relevant over time, " explained Siddharth Saha, Vice President, Healthcare and Life Sciences at Frost & Sullivan. "The tried and tested platform offers first-mile connectivity and last-mile data access. It allows MedTech companies to operate across multiple clinical specialties and geographies by leveraging Siemens Healthineers' experience in navigating market complexities and regulatory compliances."

"teamplay can be the first choice for MedTech and Pharma companies looking for industry-specific digital infrastructure to accelerate their digital transformation journeys," noted Manish Marotkar | Head - Platform as a Service Business, Siemens Healthineers. "As the world slowly emerges from the COVID-19 pandemic, there is an increased appetite and appreciation for digital tools and technologies that can make healthcare personal and precise. With teamplay, we want to accelerate the digital transformations across the healthcare industry by offering an easy to connect, secure, and compliant infrastructure."

teamplay harnesses Siemens Healthineers' vertical expertise in imaging, regulatory compliance, infrastructure availability, and customer base to support its connectivity and data access capabilities. It presents MedTech companies with a range of competitive advantages, such as:

  • Access to healthcare data generated by a wide variety of data sources. teamplay uses healthcare data from multiple sources to drive digital transformation efforts and evaluate the performance of products to aid R&D.
  • Being future-ready by accessing and aggregating specific datasets.
  • Compliance with GDPR, HIPAA, and different interoperability standards (technical and semantical) to help clients address data privacy concerns while handling personal healthcare information.
  • Expansion into adjacent markets and clinical specialties. Widen geographic footprint without having to go through extensive regulatory, compliance, privacy, and security assessments.
  • Leverage the potential of data from existing networks, interconnections, and customer base. This opens up opportunities to collaborate among partners and build applications together.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Mariana Fernandez
Corporate Communications
P: +1 210 348 10 12
E: [email protected]
http://ww2.frost.com

Related Links

www.frost.com

Modal title

Also from this source

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated ...

Frost & Sullivan: UFODRIVE Receives the 2025 European New Mobility and Automotive Technology Innovation Leadership Recognition for Enhancing Customer Impact through Digital Innovation

Frost & Sullivan is pleased to announce that UFODRIVE has received the 2025 European New Mobility and Automotive Technology Innovation Leadership...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Computer Software

Computer Software

Computer Software

Computer Software

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.